Background. Individuals with schizophrenia are at greater risk for metabolic syndrome (MetS) which is associated with cognitive deficits in the general population. MetS might be potentially an important contributing factor to cognitive impairment in schizophrenia
Metabolic syndrome (MetS) and its components are highly predictive of cardiovascular diseases. The p...
Metabolic syndrome (MetS) and its components are highly predictive of cardiovascular diseases. The p...
This non-systematic review of the literature summarizes the evidence that inflammation plays a major...
More than 40% of patients with schizophrenia have an additional diagnosis of the metabolic syndrome ...
Objective: The aim of the present study is to compare the cognitive functions of patients with and w...
Cognitive impairment is one of the core symptoms of schizophrenia, and patients with schizophrenia a...
The metabolic syndrome and cognitive dysfunctions are common in patients with schizophrenia, yet the...
Background: Metabolic syndrome (MetS) is associated with mental illnesses. It is a major predictor o...
Background: Cognitive impairment is one of the core symptoms of schizophrenia, which is considered t...
Individuals with schizophrenia have high levels of medical comorbidity and cardiovascular risk facto...
Obesity, hypertension, dyslipidemia, and insulin resistance have been associated with an increased r...
BACKGROUND: Cardiovascular morbidity and mortality are higher in patients with schizophrenia than in...
Background: The bidirectional relationships between metabolic syndrome (MetS) and schizophrenia (SCZ...
Individuals with schizophrenia have high levels of medical comorbidity and cardiovascular risk facto...
Metabolic syndrome and other cardiovascular risk factors are highly prevalent in people with schizop...
Metabolic syndrome (MetS) and its components are highly predictive of cardiovascular diseases. The p...
Metabolic syndrome (MetS) and its components are highly predictive of cardiovascular diseases. The p...
This non-systematic review of the literature summarizes the evidence that inflammation plays a major...
More than 40% of patients with schizophrenia have an additional diagnosis of the metabolic syndrome ...
Objective: The aim of the present study is to compare the cognitive functions of patients with and w...
Cognitive impairment is one of the core symptoms of schizophrenia, and patients with schizophrenia a...
The metabolic syndrome and cognitive dysfunctions are common in patients with schizophrenia, yet the...
Background: Metabolic syndrome (MetS) is associated with mental illnesses. It is a major predictor o...
Background: Cognitive impairment is one of the core symptoms of schizophrenia, which is considered t...
Individuals with schizophrenia have high levels of medical comorbidity and cardiovascular risk facto...
Obesity, hypertension, dyslipidemia, and insulin resistance have been associated with an increased r...
BACKGROUND: Cardiovascular morbidity and mortality are higher in patients with schizophrenia than in...
Background: The bidirectional relationships between metabolic syndrome (MetS) and schizophrenia (SCZ...
Individuals with schizophrenia have high levels of medical comorbidity and cardiovascular risk facto...
Metabolic syndrome and other cardiovascular risk factors are highly prevalent in people with schizop...
Metabolic syndrome (MetS) and its components are highly predictive of cardiovascular diseases. The p...
Metabolic syndrome (MetS) and its components are highly predictive of cardiovascular diseases. The p...
This non-systematic review of the literature summarizes the evidence that inflammation plays a major...
DOI
Add to ORKG